Fidelity Investments’s MAIA Biotechnology MAIA Stock Holding History

Fidelity Investments’s Portfolio MAIA Stock Details MAIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2	Buy	+2	New	+$4	﹤0.01%	5403

Other funds holding MAIA

SCM

Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

CWM

Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments's MAIA Position: Q1 2026 in Review

Fidelity Investments opened a new position in MAIA Biotechnology (MAIA) in Q1 2026: 2 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #5403 among its holdings.

33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

Fidelity Investments held 2 shares of MAIA Biotechnology worth $2 as of Q1 2026.
MAIA Biotechnology was a new Fidelity Investments position in Q1 2026.
MAIA Biotechnology made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5403 holding.
33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.